Integration of a podcast curriculum (PC) to improve hematology oncology fellow (HOF) knowledge: A multi-center cluster randomized control trial.

V Vivek Patel K Karine Tawagi (2University of Illinois Chicago, Chicago, United States) S Samantha Ann Armstrong (Indiana University School of Medicine, Indianapolis, IN) D Daniel Hausrath (2Vanderbilt University Medical Center, Nashville, United States) I Inas Abuali (Mass General Brigham Cancer Institute, Boston, MA) S Sean Maximillian Taasan (UT Southwestern Medical Center, Dallas, TX) A Ankoor Biswas (Aurora Cancer Care, Aurora Health Care, Milwaukee, WI) J Jonathan L. Berry (Beth Israel Deaconess Medical Center, Boston, MA) S Srijan Valasapalli (4East Carolina State University, Hematology Oncology, Greenville, United States) K Kyle Kidwell (University of Alabama at Birmingham, Birmingham, AL) A Agrima Mian (1Cleveland Clinic Foundation, Department of Hematology and Medical Oncology, Cleveland, United States) S Shivang Danak (Chesapeake Oncology Hematology Associates, Annapolis, MD) M Moriah Forster (Vanderbilt University Medical Center, Nashville, TN) J Jessica M. Stempel (Division of Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, OR) P Pranali Santhoshini Pachika (Charleston Regional Medical Center, Charleston, WV) M Maya Abdallah (2Boston Medical Center, Boston, United States) S Sheila DeYoung (Cooper University Hospital, Camden, NJ) L Lauren Mendelson (University of Cincinnati, Cincinnati, OH) M Megan Elizabeth Melody (Northwestern University Feinberg School of Medicine, Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL) R Ronak Mistry (2University of Pennsylvania Perelman School of Medicine, Division of Hematology/Oncology, Philadelphia, United States)

Abstract

9001 Background: Medical podcasts are widely used as learning resources, yet their integration into fellowship curricula remains unstudied. We present the final analysis of a multicenter cluster randomized trial comparing a supplemental PC with the standard curriculum (SC) to SC alone for HOFs. Methods: Twenty-seven U.S. HOF programs were randomized to receive a novel PC with SC (podcast arm) or SC alone (control arm). The PC arm accessed a website with links to podcast episodes (PEs) and show notes covering breast cancer (BC), myeloma (MM), bleeding disorders (BD), and heparin induced thrombocytopenia (HIT). PEs were developed by The Fellow on Call and Two Onc Docs podcasts. Show notes were developed by The Fellow on Call . Pre- and post-intervention qualitative surveys (QS) and knowledge assessments (KA) were administered via REDCap. HOFs rated their comfort managing topics using a 7-point Likert scale. The KA was a 16-question multiple-choice test. ANCOVA analysis was used to compared post-intervention results. This study was powered for dual primary endpoints of mean QS improvement by 0.5 and KA improvement by 10% as previously published. Results: Pre-intervention QS and KA were completed by 220 (52%) and 187 (45%) HOFs, respectively. Post-intervention, 53/107 (49%) HOFs in the podcast arm and 46/113 (40%) in the control arm completed assessments. PGY distribution was similar between podcast and control arms: PGY 4 25% and 37%, PGY 5 32% and 30%, and PGY 6+ 43% and 33% (p=0.38). At baseline, 37 (69%) podcast-arm and 24 (52%) control-arm HOFs listened to medical podcasts. Detailed didactic characteristics for each institution and HOF learning preferences were previously presented. Baseline mean comfort levels (±SD) were comparable in podcast vs. control: BC (4.4±1.5 vs. 4.5±1.4), MM (4.5±1.2 vs. 4.4±1.4), BD (3.9±1.2 vs. 3.7±1.2), and HIT (5.5±1 vs. 5.5±1). Post-intervention paired mean comfort level difference (±SD) significantly improved in the podcast vs. control across topics (p<0.01): BC (1.4±0.4 vs. 0.9±0.2), MM (1.5±0.4 vs. 0.9±0.3), BD (1.6±0.3 vs. 1±0.2), and HIT (1.2±0.6 vs. 0.8±0.4). Composite mean KA improved from 39.7%±18.9 to 62%±19.2 in the podcast arm vs. 43.5%±19.2 to 50.3%±19.8 in the control arm. The podcast arm had significantly greater improvement with an adjusted mean difference of 15.5% (p<0.01). In the podcast arm, 44 (83%) utilized >50% of show notes and found them helpful, and 47 (89%) planned to continue using these podcasts. Results were not impacted after adjusting for baseline podcast use. Conclusions: To our knowledge, this is the largest cluster randomized trial of a pragmatic educational intervention in graduate medical education. The study met its dual primary endpoints, demonstrating that the podcasts significantly improved fellow comfort and knowledge in representative topics. Despite limitations of dropout and respondent bias, findings support integrating these podcasts as a recommended resource in hematology oncology education.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
Pages 9001-9001
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (20)

V

Vivek Patel

K

Karine Tawagi

2University of Illinois Chicago, Chicago, United States

S

Samantha Ann Armstrong

Indiana University School of Medicine, Indianapolis, IN

D

Daniel Hausrath

2Vanderbilt University Medical Center, Nashville, United States

I

Inas Abuali

Mass General Brigham Cancer Institute, Boston, MA

S

Sean Maximillian Taasan

UT Southwestern Medical Center, Dallas, TX

A

Ankoor Biswas

Aurora Cancer Care, Aurora Health Care, Milwaukee, WI

J

Jonathan L. Berry

Beth Israel Deaconess Medical Center, Boston, MA

S

Srijan Valasapalli

4East Carolina State University, Hematology Oncology, Greenville, United States

K

Kyle Kidwell

University of Alabama at Birmingham, Birmingham, AL

A

Agrima Mian

1Cleveland Clinic Foundation, Department of Hematology and Medical Oncology, Cleveland, United States

S

Shivang Danak

Chesapeake Oncology Hematology Associates, Annapolis, MD

M

Moriah Forster

Vanderbilt University Medical Center, Nashville, TN

J

Jessica M. Stempel

Division of Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, OR

P

Pranali Santhoshini Pachika

Charleston Regional Medical Center, Charleston, WV

M

Maya Abdallah

2Boston Medical Center, Boston, United States

S

Sheila DeYoung

Cooper University Hospital, Camden, NJ

L

Lauren Mendelson

University of Cincinnati, Cincinnati, OH

M

Megan Elizabeth Melody

Northwestern University Feinberg School of Medicine, Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL

R

Ronak Mistry

2University of Pennsylvania Perelman School of Medicine, Division of Hematology/Oncology, Philadelphia, United States